Module 1 2021

 Clinical effectiveness  Cost-effectiveness  Budget impact  Uncertainty  Other factors?  Economic burden  Wider societal benefits  Politics  Patient/Professional input HTA Decision Making

47

HTA Decisions

 “Yes”  “No”  “Yes, but……”  Indications

 Population sub-groups  Previous treatments

48

24